LorraineCTsuiMD

PubMed

• Cystic fibrosis mutations and associated haplotypes in Turkish cystic fibrosis patients.
  Onay T, Zielenski J, Topaloglu O, Gokgoz N, Kayserili H, Apak MY, Camcioglu Y, Cokugras H, Akcakaya N, Tsui LC, Kirdar B> ;Hum. Biol.. 2001-04-01
• Spectrum of mutations in the CFTR gene of patients with classical and atypical forms of cystic fibrosis from southwestern Sweden: identification of 12 novel mutations.
  Strandvik B, Björck E, Fallström M, Gronowitz E, Thountzouris J, Lindblad A, Markiewicz D, Wahlström J, Tsui LC, Zielenski J> ;Genet. Test.. 2001-01-01
• Mutations in the cystic fibrosis transmembrane regulator gene in patients with tropical calcific pancreatitis.
  Bhatia E, Durie P, Zielenski J, Lam D, Sikora SS, Choudhuri G, Tsui LC> ;Am. J. Gastroenterol.. 2000-12-01
• Novel cystic fibrosis mutation (2215insG) in two adolescent Taiwanese siblings.
  Wu CL, Shu SG, Zielenski J, Chiang CD, Tsui LC> ;J. Formos. Med. Assoc.. 2000-07-01
• Spectrum of CFTR mutations in Mexican cystic fibrosis patients: identification of five novel mutations (W1098C, 846delT, P750L, 4160insGGGG and 297-1G-->A).
  Orozco L, Velázquez R, Zielenski J, Tsui LC, Chávez M, Lezana JL, Saldaña Y, Hernández E, Carnevale A> ;Hum. Genet.. 2000-03-01
• Cystic fibrosis gene mutations and infertile men with primary testicular failure.
  Mak V, Zielenski J, Tsui LC, Durie P, Zini A, Martin S, Longley TB, Jarvi KA> ;Hum. Reprod.. 2000-02-01
• [Analysis of mutations in the CFTR gene in patients diagnosed with cystic fibrosis in Poland].
  Aznarez I, Bal J, Casals T, Estivill X, Moral N, Sands D, Nunes V, Sobczyńska-Tomaszewska A, Tsui LC, Zielenski J> ;Med Wieku Rozwoj. 2000-01-01
• An embryoprotective role for glucose-6-phosphate dehydrogenase in developmental oxidative stress and chemical teratogenesis.
  Nicol CJ, Zielenski J, Tsui LC, Wells PG> ;FASEB J.. 2000-01-01
• Proportion of cystic fibrosis gene mutations not detected by routine testing in men with obstructive azoospermia.
  Mak V, Zielenski J, Tsui LC, Durie P, Zini A, Martin S, Longley TB, Jarvi KA> ;JAMA. 1999-06-16
• Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13.
  Zielenski J, Corey M, Rozmahel R, Markiewicz D, Aznarez I, Casals T, Larriba S, Mercier B, Cutting GR, Krebsova A, Macek M, Langfelder-Schwind E, Marshall BC, DeCelie-...> ;Nat. Genet.. 1999-06-01
• Variation in the AU(AT)-rich element within the 3'-untranslated region of PPP1R3 is associated with variation in plasma glucose in aboriginal Canadians.
  Hegele RA, Harris SB, Zinman B, Wang J, Cao H, Hanley AJ, Tsui LC, Scherer SW> ;J. Clin. Endocrinol. Metab.. 1998-11-01
• Genetic variation in paraoxonase-2 is associated with variation in plasma lipoproteins in Canadian Oji-Cree.
  Hegele RA, Harris SB, Connelly PW, Hanley AJ, Tsui LC, Zinman B, Scherer SW> ;Clin. Genet.. 1998-11-01
• Heterogeneity of reproductive tract abnormalities in men with absence of the vas deferens: role of cystic fibrosis transmembrane conductance regulator gene mutations.
  Jarvi K, McCallum S, Zielenski J, Durie P, Tullis E, Wilchanski M, Margolis M, Asch M, Ginzburg B, Martin S, Buckspan MB, Tsui LC> ;Fertil. Steril.. 1998-10-01
• Genetic variation in paraoxonase-1 and paraoxonase-2 is associated with variation in plasma lipoproteins in Alberta Hutterites.
  Boright AP, Connelly PW, Brunt JH, Scherer SW, Tsui LC, Hegele RA> ;Atherosclerosis. 1998-07-01
• Uncertainty in the diagnosis of cystic fibrosis: possible role of in vivo nasal potential difference measurements.
  Wilson DC, Ellis L, Zielenski J, Corey M, Ip WF, Tsui LC, Tullis E, Knowles MR, Durie PR> ;J. Pediatr.. 1998-04-01
• Analysis of the CFTR gene in Turkish cystic fibrosis patients: identification of three novel mutations (3172delAC, P1013L and M1028I).
  Onay T, Topaloglu O, Zielenski J, Gokgoz N, Kayserili H, Camcioglu Y, Cokugras H, Akcakaya N, Apak M, Tsui LC, Kirdar B> ;Hum. Genet.. 1998-02-01
• Higher proportion of intact exon 9 CFTR mRNA in nasal epithelium compared with vas deferens.
  Mak V, Jarvi KA, Zielenski J, Durie P, Tsui LC> ;Hum. Mol. Genet.. 1997-11-01
• Paraoxonase-2 gene (PON2) G148 variant associated with elevated fasting plasma glucose in noninsulin-dependent diabetes mellitus.
  Hegele RA, Connelly PW, Scherer SW, Hanley AJ, Harris SB, Tsui LC, Zinman B> ;J. Clin. Endocrinol. Metab.. 1997-10-01
• Paraoxonase-2 G148 variant in an aboriginal Canadian girl with non-insulin-dependent diabetes.
  Hegele RA, Connelly PW, Scherer SW, Hanley AJ, Harris SB, Tsui LC, Zinman B> ;Lancet. 1997-09-13
• Two novel frameshift deletions (1924del7, 2055del9-->A) in the CFTR gene in Mexican cystic fibrosis patients.
  Orozco L, Zielenski J, Markiewicz D, Villarreal T, Tsui LC, Lezana JL, del Angel RM> ;Hum. Mutat.. 1997-01-01
• Identification of two mutations (S50Y and 4173delC) in the CFTR gene from patients with congenital bilateral absence of vas deferens (CBAVD).
  Zielenski J, Patrizio P, Markiewicz D, Asch RH, Tsui LC> ;Hum. Mutat.. 1997-01-01
• Screening for genetic mutations.
  Carlsson C, Jonsson M, Nordén B, Dulay MT, Zare RN, Noolandi J, Nielsen PE, Tsui LC, Zielenski J> ;Nature. 1996-03-21
• Haplotype analysis of 94 cystic fibrosis mutations with seven polymorphic CFTR DNA markers.
  Morral N, Dörk T, Llevadot R, Dziadek V, Mercier B, Férec C, Costes B, Girodon E, Zielenski J, Tsui LC, Tümmler B, Estivill X> ;Hum. Mutat.. 1996-01-01
• Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations.
  Wilschanski M, Zielenski J, Markiewicz D, Tsui LC, Corey M, Levison H, Durie PR> ;J. Pediatr.. 1995-11-01
• CFTR gene variant for patients with congenital absence of vas deferens.
  Zielenski J, Patrizio P, Corey M, Handelin B, Markiewicz D, Asch R, Tsui LC> ;Am. J. Hum. Genet.. 1995-10-01
• Join now to see all